NR2F6 and central nervous system cancer: We found that high expression of NR2F6 was closely related to high tumor aggressiveness and predicted a poor outcome, and that NR2F6 expression was involved in glioma immunosuppression, tumor invasion, and progression in the inflammatory microenvironment of glioma.